Interestingly, serum ficolin-2 concentrations were higher in chronic HBV patients than in healthy controls and HBV carriers and decreased with positive treatment response, but was lowest in individuals with hepatocellular carcinoma and cirrhosis (60). This evidence concerns the gene FCN2 and hepatocellular carcinoma.